Search

everythinglearnresearchcommunity

for

Search:↓

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Existing drugs are being repurposed to treat cardiometabolic disorders, which is safer, faster, and cheaper than developing new drugs.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

New drugs for heart disease may be developed from molecules secreted by stem cells.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Intense exercise at night can delay the body's internal clock gene expression by 2 to 4 hours.

Young adults with hair loss face higher risk of stiff arteries.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.